气管导管外涂抹地塞米松、利多卡因凝胶和甘油润肤剂预防术后嗓音嘶哑、咽喉痛和喉痉挛的疗效比较

以下文章来源于小麻哥的日常 ，作者两只小绵羊

本文由“小麻哥的日常”授权转载

气管导管外涂抹地塞米松、利多卡因凝胶和甘油润肤剂预防术后嗓音嘶哑、咽喉痛和喉痉挛的疗效比较

在全身麻醉期间，使用金属喉镜通过咽部和喉部的软组织插入相对硬的气管内导管，同时应用加压套囊，可导致不同程度的组织创伤和不良结果。

麻醉医师通常会遇到术后问题，如声音嘶哑、喉咙痛和喉痉挛。

本研究旨在比较局部应用地塞米松润肤剂、利多卡因凝胶和甘油润肤剂在减少这些并发症方面的有效性。

100例患者随机分为4组，每组25例：对照组(C组)，利多卡因凝胶组(L组)，甘油润肤剂组(G组)，地塞米松润肤剂组(D组)。

将分配的药物局部应用于气管插管，并在最初24小时内监测患者术后是否出现喉痉挛、声音嘶哑和喉咙痛。

在人口统计学特征、术后咽喉痛、声音嘶哑或喉痉挛方面，四组之间未发现统计学显著差异(p>0.05)。

利多卡因凝胶是降低术后咽喉痛发生率的有效药物。

关键字：地塞米松润肤剂；气管内；术后声音嘶哑。

Comparing the effectiveness of topical dexamethasone emollient, lidocaine gel, and glycerin emollient on the endotracheal tube for postoperative hoarseness of voice, sore throat, and laryngospasm

During general anesthesia, inserting a relatively stiff endotracheal tube using a metallic laryngoscope through the soft tissues of the pharynx and larynx, along with applying a pressured cuff, can result in varying degrees of tissue trauma and adverse outcomes. Anesthesiologists commonly encounter post-operative issues such as hoarseness, sore throat, and laryngospasm. This study aimed to compare the effectiveness of topical applications of dexamethasone emollient, lidocaine gel, and glycerin emollient in reducing these complications. One hundred patients were randomly assigned to four groups of 25 patients each: the control group (Group C), lidocaine gel group (Group L), glycerin emollient group (Group G), and dexamethasone emollient group (Group D). The assigned medication was topically applied to the endotracheal tube, and patients were monitored for postoperative laryngospasm, hoarseness, and sore throat within the first 24 hours. No statistically significant differences were found among the four groups in terms of demographic characteristics, postoperative sore throat, hoarseness, or laryngospasm (p>0.05). Lidocaine gel was an effective drug that can be used to attenuate the incidence rate of post-operative sore throat.

Keywords: dexamethasone emollient; endotracheal; post-operative hoarseness

免责声明：

本微信公众平台所刊载原创或转载内容不代表米勒之声的观点或立场。文中所涉及药物使用、疾病诊疗等内容仅供医学专业人士参考。

END

编辑：Michel.米萱

校对：MiSuper.米超 

打赏